CozzaniEIurloAMerloGet al. Essential thrombocythemia: the dermatologic point of view. Clin Lymphoma Myeloma Leukemia. 2015;15(12):739-747.
2.
BoydASNeldnerKH.Hydroxyurea therapy. J Am Acad Dermatol. 1991;25(3):518-524.
3.
YarbroJW.Mechanism of action of hydroxyurea. Semin Oncol. 1992;19(3):1-10.
4.
MurrayNPTapiaPPorcellJet al. Acquired melanonychia in Chilean patients with essential thrombocythemia treated with hydroxyurea: a report of 7 clinical cases and review of the literature. ISRN Dermatol. 2013;2013:325246.
5.
AsteNFumoGContuFAsteNBiggioP.Nail pigmentation caused by hydroxyurea: report of 9 cases. J Am Acad Dermatol. 2002;47(1):146-147.
6.
VomvourasSPakulaASShawJM.Multiple pigmented nail bands during hydroxyurea therapy: an uncommon finding. J Am Acad Dermatol. 1991;24(6):1016-1017.
7.
HendrixJDGreerKE.Cutaneous hyperpigmentation caused by systemic drugs. Int J Dermatol. 1992;31(7):458-466.
8.
MurrayNPEchavarríaMReculéFMirandaMFerresÁ.Acquired hyperpigmentation of the tongue associated with hydroxyurea: case report of a very rare location of a rare adverse effect. Global J Dermatol Venereol. 2016;4(1):12-13.
9.
FabrisFRandiML.Essential thrombocythemia: past and present. Intern Emerg Med. 2009;4(5):381-388.
10.
MajumdarGHeardSESlaterNG.Reversible hyperpigmentation associated with high dose hydroxyurea. BMJ. 1990;300(6737):1468.
11.
GropperCADonPCSadjadiMM.Nail and skin hyperpigmentation associated with hydroxyurea therapy for polycythemia vera. Int J Dermatol. 1993;32(10):731-733.
12.
LaughonSKShinnLLNunleyJR.Melanonychia and mucocutaneous hyperpigmentation due to hydroxyurea use in an HIV-infected patient. Int J Dermatol. 2000;39(12):928-931.
IssaivananMMituPSManishaCPraveenK.Cutaneous manifestations of hydroxyurea therapy in childhood: case report and review. Pediatr Dermatol. 2004;21(2):124-127.
15.
KumarBSaraswatAKaurI.Mucocutaneous adverse effects of hydroxyurea: a prospective study of 30 psoriasis patients. Clin Exp Dermatol. 2002;27(1):8-13.
16.
AlgarraACMiguelRARomeroFTJimenezLM.Mucocutaneous lesions and nail pigmentation in a patient with essential thrombocytosis. Aust Family Phys. 2017;46(4):222.
